• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卵巢透明细胞癌脑转移:一例报告

Brain metastasis from ovarian clear cell carcinoma: A case report.

作者信息

Liu Ping, Liu Wei, Feng Yuhua, Xiao Xiangyu, Zhong Meizuo

机构信息

Department of Oncology, Xiang Ya Hospital, Central South University, China.

出版信息

Medicine (Baltimore). 2019 Jan;98(3):e14020. doi: 10.1097/MD.0000000000014020.

DOI:10.1097/MD.0000000000014020
PMID:30653108
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6370159/
Abstract

RATIONALE

Epithelial ovarian carcinoma (EOC) is the most common type of ovarian carcinoma, and the leading cause of female genital tract cancer-related deaths. However, brain metastasis (BM) of EOC is rare, with an incidence of only 1% to 2%. Ovarian clear cell carcinoma (OCCC), accounting for 5% to 25% of all EOC cases, has a poor prognosis compared with other epithelial cell type carcinomas.

PATIENT CONCERNS

We retrospectively analyzed the clinical data of a 62-year-old female, who was hospitalized with the main complaint of BM detection for 1 month. She was first diagnosed with ovarian cancer in 2004, and underwent a left oophorectomy. Three years later, the cancer metastasized to the other side, and she underwent a right oophorectomy, followed by 7 courses of platinum-based chemotherapy. She received regular follow-up, and tumor markers and pelvic imaging did not show any signs of progression until July 2012.

DIAGNOSIS

Combining the clinical manifestations with the results of radiological and pathological examinations, the findings were consistent with a diagnosis of BM from OCCC.

INTERVENTIONS

She received more than 20 courses of chemotherapy since July 2012. The BM was detected in 2016, and she underwent an intracranial lesion resection.

OUTCOMES

Unfortunately, the patient went into a coma after the surgery, and passed away 1 month later.

LESSONS

For early detection of BM in long-term ovarian cancer, emphasis should be placed on the patient's neurological symptoms and signs as well as serum tumor marker changes. The combination of surgery, radiology, and chemotherapy may achieve long overall survival.

摘要

理论依据

上皮性卵巢癌(EOC)是卵巢癌最常见的类型,也是女性生殖道癌症相关死亡的主要原因。然而,EOC的脑转移(BM)很少见,发病率仅为1%至2%。卵巢透明细胞癌(OCCC)占所有EOC病例的5%至25%,与其他上皮细胞类型的癌相比,预后较差。

患者情况

我们回顾性分析了一名62岁女性的临床资料,她因检测出BM住院1个月。她于2004年首次被诊断为卵巢癌,并接受了左侧卵巢切除术。三年后,癌症转移至另一侧,她接受了右侧卵巢切除术,随后进行了7个疗程的铂类化疗。她接受了定期随访,直到2012年7月肿瘤标志物和盆腔影像学检查均未显示任何进展迹象。

诊断

结合临床表现以及放射学和病理学检查结果,诊断结果与OCCC脑转移相符。

干预措施

自2012年7月起,她接受了20多个疗程的化疗。2016年检测出BM,她接受了颅内病变切除术。

结果

不幸的是,患者术后昏迷,1个月后去世。

经验教训

对于长期卵巢癌患者脑转移的早期检测,应重视患者的神经症状和体征以及血清肿瘤标志物的变化。手术、放射学和化疗相结合可能实现较长的总生存期。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38d1/6370159/9c4ad1561a1c/medi-98-e14020-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38d1/6370159/746a22af7f91/medi-98-e14020-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38d1/6370159/9674d5554356/medi-98-e14020-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38d1/6370159/37722b3d82d8/medi-98-e14020-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38d1/6370159/9c4ad1561a1c/medi-98-e14020-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38d1/6370159/746a22af7f91/medi-98-e14020-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38d1/6370159/9674d5554356/medi-98-e14020-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38d1/6370159/37722b3d82d8/medi-98-e14020-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38d1/6370159/9c4ad1561a1c/medi-98-e14020-g004.jpg

相似文献

1
Brain metastasis from ovarian clear cell carcinoma: A case report.卵巢透明细胞癌脑转移:一例报告
Medicine (Baltimore). 2019 Jan;98(3):e14020. doi: 10.1097/MD.0000000000014020.
2
Brain metastases in patients with EOC: Clinico-pathological and prognostic factors. A multicentric retrospective analysis from the MITO group (MITO 19).上皮性卵巢癌患者的脑转移:临床病理及预后因素。一项来自MITO研究组(MITO 19)的多中心回顾性分析。
Gynecol Oncol. 2016 Dec;143(3):532-538. doi: 10.1016/j.ygyno.2016.09.025. Epub 2016 Oct 5.
3
A late, solitary brain metastasis of epithelial ovarian carcinoma.上皮性卵巢癌的晚期孤立性脑转移瘤。
BMC Cancer. 2014 Jul 28;14:543. doi: 10.1186/1471-2407-14-543.
4
Radiation therapy for epithelial ovarian cancer brain metastases: clinical outcomes and predictors of survival.上皮性卵巢癌脑转移的放射治疗:临床结果和生存预测因素。
Radiat Oncol. 2013 Feb 15;8:36. doi: 10.1186/1748-717X-8-36.
5
Primary clear cell adenocarcinoma of the fallopian tube with brain metastasis: a case report.原发性输卵管透明细胞腺癌伴脑转移:一例报告
Asia Oceania J Obstet Gynaecol. 1994 Jun;20(2):135-40. doi: 10.1111/j.1447-0756.1994.tb00439.x.
6
Synchronous occurrence of primary right ovarian endometrioid adenocarcinoma and primary left ovarian clear cell adenocarcinoma: A case report.原发性右卵巢子宫内膜样腺癌与原发性左卵巢透明细胞腺癌同步发生:一例报告。
Medicine (Baltimore). 2018 Jul;97(27):e11330. doi: 10.1097/MD.0000000000011330.
7
Staging Lymphadenectomy in Patients With Clear Cell Carcinoma of the Ovary.卵巢透明细胞癌患者的分期淋巴结切除术
Int J Gynecol Cancer. 2016 Jan;26(1):120-4. doi: 10.1097/IGC.0000000000000559.
8
Management of brain metastasis in a patient with advanced epithelial ovarian carcinoma by gamma-knife radiosurgery.伽玛刀放射外科治疗晚期上皮性卵巢癌患者脑转移瘤
Srp Arh Celok Lek. 2015 Mar-Apr;143(3-4):205-9. doi: 10.2298/sarh1504205n.
9
Hyperamylasemia may indicate the presence of ovarian carcinoma: A case report.高淀粉酶血症可能提示卵巢癌的存在:一例报告。
Medicine (Baltimore). 2018 Dec;97(49):e13520. doi: 10.1097/MD.0000000000013520.
10
[A case of brain metastasis from advanced ovarian clear-cell carcinoma during maintenance chemotherapy with irinotecan+cisplatin].[1例晚期卵巢透明细胞癌在伊立替康+顺铂维持化疗期间发生脑转移]
Gan To Kagaku Ryoho. 2008 Jul;35(7):1243-5.

引用本文的文献

1
Updates of Pathogenesis, Diagnostic and Therapeutic Perspectives for Ovarian Clear Cell Carcinoma.卵巢透明细胞癌发病机制、诊断与治疗前景的最新进展
J Cancer. 2021 Feb 22;12(8):2295-2316. doi: 10.7150/jca.53395. eCollection 2021.
2
Prognostic Factors among Brain Metastases in Newly Diagnosed Ovary Cancer: A Large Real-world Study.新诊断卵巢癌脑转移的预后因素:一项大型真实世界研究
J Cancer. 2020 May 18;11(15):4625-4640. doi: 10.7150/jca.44494. eCollection 2020.

本文引用的文献

1
Does serum CA125 have clinical value for follow-up monitoring of postoperative patients with epithelial ovarian cancer? Results of a 12-year study.血清CA125对上皮性卵巢癌术后患者的随访监测有临床价值吗?一项12年研究的结果。
J Ovarian Res. 2017 Mar 11;10(1):14. doi: 10.1186/s13048-017-0310-y.
2
Brain metastases in patients with EOC: Clinico-pathological and prognostic factors. A multicentric retrospective analysis from the MITO group (MITO 19).上皮性卵巢癌患者的脑转移:临床病理及预后因素。一项来自MITO研究组(MITO 19)的多中心回顾性分析。
Gynecol Oncol. 2016 Dec;143(3):532-538. doi: 10.1016/j.ygyno.2016.09.025. Epub 2016 Oct 5.
3
Improving drug delivery to primary and metastatic brain tumors: strategies to overcome the blood-brain barrier.
改善原发性和转移性脑肿瘤的药物递送:克服血脑屏障的策略。
Clin Pharmacol Ther. 2015 Apr;97(4):336-46. doi: 10.1002/cpt.71. Epub 2015 Feb 18.
4
Metastatic ovarian carcinoma to the brain: an approach to identification and classification for neuropathologists.脑转移性卵巢癌:神经病理学家的识别与分类方法
Neuropathology. 2015 Apr;35(2):122-9. doi: 10.1111/neup.12172. Epub 2014 Nov 6.
5
Brain metastasis from ovarian cancer: a systematic review.卵巢癌脑转移:一项系统综述
J Neurooncol. 2014 Aug;119(1):1-6. doi: 10.1007/s11060-014-1447-9. Epub 2014 May 1.
6
[A case of brain metastasis from advanced ovarian clear-cell carcinoma during maintenance chemotherapy with irinotecan+cisplatin].[1例晚期卵巢透明细胞癌在伊立替康+顺铂维持化疗期间发生脑转移]
Gan To Kagaku Ryoho. 2008 Jul;35(7):1243-5.
7
Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers.与其他上皮细胞类型相比,透明细胞卵巢癌的预后是否更差?一项对1411例透明细胞卵巢癌的研究。
Gynecol Oncol. 2008 Jun;109(3):370-6. doi: 10.1016/j.ygyno.2008.02.006. Epub 2008 Apr 18.
8
Gamma-knife radiosurgery as an optimal treatment modality for brain metastases from epithelial ovarian cancer.伽玛刀放射外科作为上皮性卵巢癌脑转移的一种最佳治疗方式。
Gynecol Oncol. 2008 Mar;108(3):505-9. doi: 10.1016/j.ygyno.2007.11.027. Epub 2008 Jan 11.
9
Brain metastases in patients with ovarian carcinoma: prognostic factors and outcome.卵巢癌患者的脑转移:预后因素与结局
J Neurooncol. 2004 Feb;66(3):313-25. doi: 10.1023/b:neon.0000014516.04943.38.
10
Evaluation of prognostic factors and treatment modalities in ovarian cancer patients with brain metastases.
Gynecol Oncol. 2002 Jun;85(3):487-92. doi: 10.1006/gyno.2002.6653.